Skip to main content

Efficacy of prolonged ingestion of Lactobacillus acidophilus L-92 in adult patients with atopic dermatitis.

  • 2016-07
  • Journal of Dairy Science 99(7)
    • Kozo Yamamoto
    • K. Yokoyama
    • Takehisa Matsukawa
    • Sayaka Kato
    • S. Kato
    • Kazuhisa Yamada
    • Tatsuhiko Hirota

Abstract

To evaluate the safety and efficacy of prolonged ingestion of Lactobacillus acidophilus L-92 (L-92) on skin symptoms in adult atopic dermatitis (AD) patients, a placebo-controlled double-blinded parallel-group comparison study was performed. This included daily administration of heat-killed and dried L-92 or placebo for 24wk in 50 AD patients who were 16yr old or older. The severity of skin symptoms was evaluated at baseline and at 4, 8, 12, 16, 20, and 24wk during the intervention using the investigator global assessment, eczema area and severity index, and scoring atopic dermatitis. Serum cytokine and blood marker levels were also measured at baseline and at 4, 8, 16, and 24wk during the intervention. No adverse events were reported during the study period. Compared with the placebo group, the L-92 group showed significant decreases in investigator global assessment, eczema area and severity index, and scoring atopic dermatitis. Subjective symptoms in adult AD patients were reduced by intake of L-92. Furthermore, it was suggested that sustained ingestion of L-92 resulted in suppression of scratching behavior and maintenance of remission status of skin symptoms. Sixteen weeks after the study commenced, a significant decrease in lactate dehydrogenase and a significant increase in transforming growth factor-β were observed in the L-92 group compared with the placebo group. In the L-92 group, a significant elevation of IL-12 (p70) level at the end of treatment period compared with before the treatment was observed. This study suggested that L-92 suppresses type-2-helper-T-cell-dominant inflammation by activating regulatory T cells and type 1 helper T cells.

Keywords: Lactobacillus acidophilus; allergy; atopic dermatitis; placebo-controlled double-blinded parallel-group comparison study.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus acidophilus L-92Improved Skin SymptomsBeneficial
Large
Lactobacillus acidophilus L-92Increased IL-12 LevelsBeneficial
Moderate
Lactobacillus acidophilus L-92Increased Transforming Growth Factor-β LevelsBeneficial
Moderate
Lactobacillus acidophilus L-92Reduced Lactate Dehydrogenase LevelsBeneficial
Moderate
Lactobacillus acidophilus L-92Reduced Subjective SymptomsBeneficial
Moderate
Lactobacillus acidophilus L-92Reduced Type-2-helper-T-cell-dominant InflammationBeneficial
Moderate

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.